Sjögren’s syndrome is not directly inherited like a single-gene disorder, but genetics play a significant role in who develops it. Having a first-degree relative with Sjögren’s raises your risk roughly 12 times compared to the general population. The disease results from a combination of inherited susceptibility genes, biological sex, epigenetic changes, and environmental triggers, meaning no single factor is enough on its own.
Family Risk by the Numbers
A nationwide population study in Taiwan quantified the familial risk with striking clarity. Siblings of someone with Sjögren’s had about 19 times the risk of developing it themselves. Offspring of affected parents had roughly 11 times the risk, and parents of affected individuals had about 12.5 times the risk. Twins showed the most dramatic numbers: co-twins of patients with Sjögren’s had over 660 times the risk of the general population, though the study included both identical and fraternal twins in that figure.
To put these numbers in perspective, the prevalence of Sjögren’s in Taiwan’s general population was about 0.05%. Among people who had at least one first-degree relative with the disease, prevalence rose to 0.48%. That’s nearly ten times higher, but still well under 1%. So while the relative increase in risk is large, the absolute chance of developing Sjögren’s remains low even if a close family member has it.
Families with Sjögren’s also tend to cluster with other autoimmune diseases. In families identified through lupus, primary and secondary Sjögren’s appeared within the same families at rates far above chance. Relatives without lupus who had primary Sjögren’s were almost five times more likely to have a lupus-affected relative who also had secondary Sjögren’s. This suggests shared genetic and possibly environmental factors underlie multiple autoimmune conditions, not just Sjögren’s alone.
Which Genes Are Involved
The strongest genetic links to Sjögren’s sit in a region of chromosome 6 called the major histocompatibility complex (MHC), which controls how your immune system recognizes threats. Two specific gene variants in this region, HLA-DRB1*03:01 and HLA-DRB1*15:01, show the most consistent association in people of European descent. These variants influence how immune cells present proteins to the rest of the immune system, and certain versions appear to increase the chance of the immune system mistakenly attacking the body’s own moisture-producing glands.
Beyond those classic markers, researchers have identified additional risk genes in the same chromosomal neighborhood. A gene called MICA, which helps regulate natural killer cells, carries a variant (MICA*008) that showed a powerful statistical association with Sjögren’s, independent of the HLA genes. Variants near genes involved in inflammation signaling, including one that affects a protein called tumor necrosis factor, also contribute to risk. Altogether, at least three distinct peaks of genetic risk have been mapped within this one region, each contributing independently.
No single gene variant causes Sjögren’s. Each one nudges risk upward by a small amount. Most people who carry these variants never develop the disease, and some people with Sjögren’s don’t carry any of the known risk variants. Genetic testing for these markers is not currently part of clinical diagnosis. Sjögren’s is diagnosed through a combination of symptom assessment, eye and saliva tests, salivary gland biopsy, and blood tests for specific autoantibodies (anti-Ro/SSA and anti-La/SSB).
Why Women Are Far More Affected
Sjögren’s syndrome affects women at rates ranging from 6:1 to 16:1 compared to men, with the highest rates in women after menopause. This stark imbalance has a genetic explanation rooted in the X chromosome. Women carry two X chromosomes, and certain immune-related genes on the X chromosome escape the normal silencing process that’s supposed to keep one copy quiet. The result is overexpression of genes that ramp up immune activation.
The strongest evidence comes from studies of chromosomal abnormalities. Women with triple X syndrome (three X chromosomes instead of two) have a 2.9-fold higher risk of developing Sjögren’s compared to women with normal chromosomes. Men with Klinefelter syndrome (who carry an extra X chromosome, giving them XXY) are also significantly overrepresented among Sjögren’s patients. This pattern, where more X chromosomes means more disease risk regardless of biological sex, points to a dose effect: the more copies of these immune genes you have active, the greater your susceptibility.
Epigenetic Changes in Sjögren’s
Your DNA sequence isn’t the whole story. Epigenetic modifications, chemical tags that sit on top of DNA and control which genes are turned on or off, also differ between people with Sjögren’s and healthy individuals. In patients with the disease, researchers have found a global decrease in DNA methylation (one of the main “off switches” for genes) in both salivary gland cells and immune cells from the blood. When methylation decreases, genes that would normally stay quiet become active.
This pattern of reduced methylation has been observed in specific repetitive DNA sequences in salivary glands of Sjögren’s patients. Because epigenetic changes can be influenced by aging, infections, hormones, and other environmental exposures, they represent a bridge between your inherited genes and the outside factors that ultimately trigger the disease. You can inherit a genetic predisposition, but epigenetic shifts accumulated over a lifetime may determine whether that predisposition ever activates.
Environmental Triggers in Genetically Susceptible People
Concordance rates for autoimmune diseases in identical twins, who share virtually 100% of their DNA, are typically below 30%. This means that even with identical genetics, most twins don’t both develop the same autoimmune condition. Something beyond DNA has to pull the trigger.
Epstein-Barr virus (EBV), the virus that causes mono, is one of the most studied environmental candidates for Sjögren’s. EBV can infect the same types of cells that Sjögren’s attacks, including the epithelial cells lining salivary glands and the B cells of the immune system. One proposed mechanism is molecular mimicry: proteins on the surface of EBV resemble proteins in the body’s own tissues closely enough that the immune response against the virus accidentally targets healthy glands. EBV can also directly activate immune pathways, particularly an interferon signaling cascade that’s a hallmark of Sjögren’s autoimmune activity.
Other proposed triggers include hormonal changes (which may explain the post-menopausal peak in diagnosis), chronic stress, and other viral infections, though EBV has the most evidence behind it. The current understanding is that Sjögren’s develops when a genetically susceptible person encounters the right combination of environmental exposures at the right time, tipping their immune system from normal function into self-attack.
What This Means if Sjögren’s Runs in Your Family
If a parent or sibling has Sjögren’s, your risk is meaningfully elevated compared to someone with no family history, but it’s still low in absolute terms (under 1% based on available data). There is no genetic test that can predict whether you’ll develop the disease, and no proven way to prevent it in someone who is genetically predisposed. What you can do is stay aware of early symptoms: persistent dry eyes, dry mouth, joint pain, and fatigue that doesn’t improve with rest. Sjögren’s takes an average of several years to diagnose because these symptoms overlap with many other conditions, so knowing your family history can help you and your doctor connect the dots faster if symptoms appear.
Families with one autoimmune disease often see others. If your relative has Sjögren’s, your family may carry broader autoimmune susceptibility that could manifest as lupus, rheumatoid arthritis, or thyroid disease rather than Sjögren’s specifically. Paying attention to autoimmune symptoms in general, not just dry eyes and mouth, is a practical step worth taking.